Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares of common stock in this offering. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) … Continue reading Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was -4.79% in last session and finished the day at $1.85. … Continue reading Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

On June 12, 2014, Demand Media, Inc. (NYSE:DMD) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, 84,630,271 shares were represented in person or by proxy, constituting approximately 93% of the Company’s outstanding shares as of April 21, 2014, the record date for the Annual Meeting. At the Annual Meeting, the following six proposals were submitted to the stockholders and … Continue reading Stocks In News: Demand Media Inc (NYSE:DMD), Microsoft Corporation (NASDAQ:MSFT), Google Inc (NASDAQ:GOOGL), Spark Networks Inc (NYSEMKT:LOV)

Gilead Sciences, Inc. (NASDAQ:GILD) on June 15 announced topline results from a Phase 3 clinical trial (GS-US-337-0113) in Japan evaluating the investigational once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg, with and without ribavirin (RBV), for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection. Gilead Sciences, Inc. (NASDAQ:GILD) stock … Continue reading Healthcare New Highs: Gilead Sciences (NASDAQ:GILD), Baxter International (NYSE:BAX), WellPoint (NYSE:WLP), The Cooper Companies, Inc. (NYSE:COO), iKang Healthcare (NASDAQ:KANG)

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 30,000 shares of the stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average price of $8.58 per share, for a total transaction of $257,400.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,052,750. Opko Health Inc. … Continue reading Healthcare Insider Buying: Opko Health (NYSE:OPK), American Apparel (NYSEMKT:APP), Accelerate Diagnostics Inc (NASDAQ:AXDX), Biota Pharmaceuticals Inc (NASDAQ:BOTA), Echo Therapeutics Inc (NASDAQ:ECTE)

Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the stock on the open market in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $172.89, for a total value of $363,069.00. Following the sale, the director now directly owns 12,466 shares in the company, valued at approximately $2,155,247. Illumina, Inc. (NASDAQ:ILMN) stock performance was 2.51% in last session … Continue reading Healthcare Insider Selling: Illumina (NASDAQ:ILMN), Raptor Pharmaceutical (NASDAQ:RPTP), Stryker Corporation (NYSE:SYK), United Therapeutics Corporation (NASDAQ:UTHR), CareFusion Corporation (NYSE:CFN)